Polaryx Therapeutics Inc (PLYX)
2.71
-3.21%
Polaryx Therapeutics Inc (PLYX) is currently trading at $2.71. This represents a loss of 3.21% from the previous session. With a market capitalization of $0.00B, PLYX is a key component of the Health Care sector. Investors looking to trade PLYX should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Get 15 Free Stocks on Moomoo →
T&Cs Apply. Trade PLYX commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Polaryx Therapeutics Inc (PLYX) shows a bearish trend. Analysts are watching the 2.78 level closely.
Fundamentals
Mkt Cap0.00B
P/E Ratio0.0000
Volume37,237
60-Day Technical Chart
Advanced Charting
Need more indicators for PLYX? Use the world's #1 platform.
Open PLYX on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $3
| Metric |
PLYX -3.21% |
RR +3.11% |
UIS +18.31% |
ASPN -27.67% |
|---|---|---|---|---|
| Price | $2.71 | $2.65 | $2.52 | $2.58 |
| Mkt Cap | $0.00B | $0.58B | $0.18B | $0.21B |
| - | View → | View → | View → |
Latest Headlines
Rare-disease biotech readies Phase 2 trial across four childhood disorders
Stock Titan • Feb 17, 2026
PLYX | Polaryx Therapeutics, Inc. Common Stock Data, Price & News
Quiver Quantitative • Jan 30, 2026
Biotech targeting rare pediatric diseases heads to Nasdaq Feb. 2
Stock Titan • Jan 30, 2026
PLYX Stock Price and Chart — NASDAQ:PLYX
TradingView • Nov 26, 2025
PLYX IPO News - Rare disease biotech Polaryx Therapeutics files for a direct listing on the Nasdaq
renaissancecapital.com • Nov 21, 2025
● Gemini Agentic AI Analyst Insight for PLYX
Market Education
- Trump’s New Tariffs Could Push Up Kitchen Renovation Costs Sep 26, 2025
- Want to be a Wall street billionaire, take their investing advice Jul 19, 2023
- October Market Volatility: Why Investors Fear the “Danger Month” Sep 26, 2025
External Research